Narsing Rao, interim dean of the Keck School of Medicine of USC, and glaucoma specialist Brian Song joined forces to successfully treat an uncommon, vision-threatening condition.
Roslymn Caldwell had eye problems since she was born, and was blind throughout adulthood. A consultation with USC ophthalmologist Annie Nguyen changed her life.
Their treatment could potentially become the first FDA-approved treatment for dry age-related macular degeneration.
Annie Nguyen of the USC Roski Eye Institute answers frequently asked questions on what the new coronavirus can — and cannot — do to our eyes.
The National Science Foundation has awarded an innovation grant to researchers at the USC Ginsburg Institute and the USC Roski Eye Institute to advance efforts to slow down or reverse retinal degeneration.
The award — granted by the California Institute for Regenerative Medicine — is designed to advance California as a hub of medical breakthroughs.
Parshanna Wilson works at USC Village and studies at USC Roski Eye Institute clinics around Los Angeles.
Seeking treatment at Keck Medicine of USC put these patients in the right place at the right time.
Innovative research for retinoblastoma may help children preserve their vision — and avoid risky surgery.
Retired ophthalmologist Allen Ginsburg and his wife, Charlotte, donate $10 million to name the USC Institute for Biomedical Therapeutics.
It’s the first human trial, which is designed to replace a single-cell layer that degenerates in patients with dry age-related macular degeneration.
USC scientists and engineers develop an on-the-spot, temperature-sensitive gel that could seal eye injuries on the battlefield.
The impairment will affect nearly 220,000 youngsters over the next 45 years, USC Roski Eye Institute research finds.
President Obama presents the prestigious honor recognizing contributions to American ingenuity and quality of life.
The office offers exams, lens fittings and walk-in purchases in the University Gateway building.
Teams in the Min Family Engineering Social Entrepreneurship Challenge hope to boost technology through budding businesses.
USC Eye Institute researcher takes part in clinical trials focusing on the aging eye.
A common prescription drug may help reduce cases of blindness by 75 percent in Hispanic and non-Hispanic whites.
Arizona resident has positive results from use of Argus II just one week after retinal implant.
Keck Medicine of USC research to slow vision loss for macular degeneration patients has been funded as part of the third round of the California Institute for Regenerative Medicine’s Disease Team awards.